Articles Archives - Page 35 of 748

WednesdayJul 02, 2025 10:30 am

Brera Holdings PLC (NASDAQ: BREA) Finalizes Majority Stake Acquisition in SS Juve Stabia as Club Value Soars 245%

The company has completed its acquisition of a 52% controlling stake in Italian Serie B club SS Juve Stabia. The club’s valuation rose from $9.3 million to $32.3 million over the 2024–25 season. Juve Stabia reached the semifinals of the Serie A promotion playoffs, boosting its market value. Brera’s multi-club ownership strategy aims to drive operational efficiencies and shareholder value. The acquisition highlights Brera’s ambition to expand its portfolio through strategic investments in promising clubs. Brera Holdings (NASDAQ: BREA), an Ireland-based international holding company focused on expanding its global portfolio of men’s and women’s sports clubs through a multi-club ownership…

WednesdayJul 02, 2025 9:45 am

Adageis: An AI-Powered Advocate for Healthcare Providers

Adageis, a company offering a powerful and patented AI-centric software solution, remains committed to streamlining the healthcare sector, making it easier for providers to meet their financial goals It works with over 90 Electronic Health Record platforms, an unrivalled level of access that gives its users actionable insights at the point of care The company covers over 260,000 patient lives, and looks to double that to 580,000, achieving its $100,000 monthly recurring revenue target Adageis, a company offering powerful and patented AI-based software, provides flexible healthcare and related software solutions for providers and healthcare systems. The company remains committed to…

WednesdayJul 02, 2025 9:00 am

Soligenix Inc. (NASDAQ: SNGX) Highlights Encouraging Phase 3 Progress for HyBryte(TM) in Investment Webinar

A focus during the webinar was the investigator-initiated study currently being conducted at the University of Pennsylvania under the leadership of Dr. Ellen Kim. Interim results show that among the first eight patients who completed 18 weeks of treatment, 75% demonstrated a greater than 50% reduction in disease severity. Soligenix anticipates top-line results from the phase 3 trial in the second half of 2026. In a recent webinar hosted by Allele Capital, Soligenix (NASDAQ: SNGX) executives Dr. Christopher Schaber and Dr. Christopher Pullion shared detailed updates on the company's HyBryte(TM) (synthetic hypericin) clinical development (https://ibn.fm/dz7eO). The event offered an in-depth…

TuesdayJul 01, 2025 9:45 am

Silvercorp Metals Inc. (NYSE-A: SVM) (TSX: SVM) Updated Resource Estimate for Condor Project Highlights High-Grade Underground Potential

Total indicated underground mineral resources of 3.17 million tonnes at Camp and Los Cuyes deposits, containing 0.37 million gold equivalent ounces at a cutoff grade of 2.2 g/t AuEq. Total inferred underground mineral resources of 12.1 Mt at Camp and Los Cuyes deposits, containing 1.50 million gold equivalent ounces at a cutoff grade of 2.2 g/t AuEq. Ongoing 3,500-metre drill program set to expand known mineralization zones. Preliminary Economic Assessment for underground operation expected by year-end 2025. El Domo Project development on track with detailed cost breakdown and construction timeline targeting 2026 production. Silvercorp Metals (NYSE-A: SVM) (TSX: SVM), a…

TuesdayJul 01, 2025 9:00 am

Dynamic Global Events Presents: The 6th Clinical Trial Agreements Summit

Dynamic Global Events (“DGE”) is proud to announce the 6th Clinical Trial Agreements Summit taking place August 21-22 in Philadelphia. This event will explore how to negotiate budgetary restraints, protect intellectual property and clinical data, and reduce risks in indemnification and subject injury. This summit offers a dynamic mix of panel discussions, fireside chats, solo presentations, and exclusive networking opportunities with top stakeholders across the clinical research industry. Hear from 30+ expert speakers representing leading organizations including Merck, Pfizer, Takeda, Alkermes, and many more. As clinical trial agreements form the foundation of every collaboration between sponsors, sites, and CROs, it’s essential…

MondayJun 30, 2025 10:30 am

Lahontan Gold Corp. (TSX.V: LG) (OTCQB: LGCXF) Set to Capitalize on Potential of Nevada’s Walker Lane

Nevada’s Walker Lane area is becoming a prime target for mineral exploration Lahontan Gold is focused on becoming a strategic player in the Walker Lane region Lahontan’s strategic execution, focused on resource growth and economic evaluation, mirrors the broader resurgence of Walker Lane as a target-rich environment LGCXF recently launched new metallurgical testing at its Santa Fe deposit, aiming at improving gold and silver mineralization Nevada’s Walker Lane region has emerged as one of North America’s most compelling gold and silver frontiers — and Lahontan Gold (TSX.V: LG) (OTCQB: LGCXF) is strategically placed to capitalize on that fact, owning and developing four…

MondayJun 30, 2025 9:45 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Secures Multimillion-Dollar Funding from U.S. Department of Defense to Strengthen Rare Earth Independence

Despite the critical importance of rare earth element metals, the United States has long been dependent on imports to provide an adequate supply. Ucore has secured a $18.4 million funding agreement from the U.S. DoD to support the development of its rare earth processing facility in Louisiana. Ucore CEO notes that the funding validates the company’s technological leadership, underscores the strategic value of domestic REE processing. As global competition intensifies over the control and supply of critical minerals, the United States is taking aggressive steps to secure domestic sources of rare earth elements (“REEs”)—materials essential for defense systems, electronics and clean energy.…

MondayJun 30, 2025 9:00 am

Nightfood Holdings Inc. (NGTF): Where Robots Meet Real Estate in the Future of Hospitality

NGTF combines AI-powered robotics technology with strategic hotel acquisitions, expanding into new vision for next-generation hospitality solutions Recent executive appointments have brought decades of hotel operations expertise and supply chain innovation to accelerate the company's deployment Major hotel advancements, including a LOI to acquire a $36.93 million Hilton Garden Inn deal adjacent to Disney's Cotino development, to position NGTF as a flagship automation showcase The hospitality industry stands at a technological crossroads. With shortages continuing to challenge hotel operations and guests demanding enhanced service experiences, the sector faces unprecedented pressure to innovate. Traditional staffing models are proving inadequate, with many…

FridayJun 27, 2025 10:30 am

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Breaks Ground on REE Processing Facility, Pioneers Domestic Supply Chain

The company announced the groundbreaking of its Louisiana Strategic Metals Complex (“SMC”) in Alexandria. The Louisiana SMC is designed to utilize Ucore's proprietary RapidSX(TM) technology. Ucore also announced the execution of $18.4 million in funding from the U.S. Department of Defense (“DoD”). Ucore Rare Metals (TSX.V: UCU) (OTCQX: UURAF), a critical metals technology company developing scalable rare earth element (“REE”) refining infrastructure in North America, has marked a significant milestone in the development of a domestic REE supply chain. The company announced the groundbreaking of its Louisiana Strategic Metals Complex (“SMC”) in Alexandria (https://ibn.fm/zPMiw). This facility represents the company's first…

FridayJun 27, 2025 9:45 am

NRx Pharmaceuticals Inc. (NASDAQ: NRXP) Applies for FDA Commissioner’s National Priority Voucher for IV Ketamine NRX-100

The new FDA voucher program aims to speed approval of drugs aligned with national health priorities. NRX-100, a preservative-free ketamine, is also under an Abbreviated New Drug Application (“ANDA”) with a priority review request. NRx has submitted full CMC data and draft labeling for NRX-100, meeting key Commissioner's National Priority Voucher pre-qualification criteria. The company’s U.S.-based manufacturing aims to reduce foreign supply chain dependence and address diversion concerns. A patent on the preservative-free process and a citizen petition to withdraw preserved ketamine could bolster NRx’s market position. NRx Pharmaceuticals (NASDAQ: NRXP), a clinical-stage biopharmaceutical company developing innovative treatments for suicidal…

Site Search

Company Search

Category: Articles